In the management of subacute postpartum thyroiditis, which clinical feature distinguishes it from Graves' hyperthyroidism postpartum, and what is the key difference in radioactive iodine uptake (RAIU) test results?
- A Both have elevated T3/T4 and elevated RAIU; distinguished by TRAb antibodies in Graves
- B Postpartum thyroiditis: low/suppressed RAIU (destructive thyroiditis); Graves' postpartum: elevated RAIU with elevated TRAb ✓
- C Postpartum thyroiditis: elevated TSH with RAIU suppressed; Graves: normal TSH with elevated T4
- D Both have low RAIU; distinguished by TPO antibodies in thyroiditis vs TRAb in Graves
Explanation
Postpartum thyroiditis is a lymphocytic (autoimmune) destructive thyroiditis occurring within 1 year of delivery, causing a transient hyperthyroid phase (weeks 1–4 postpartum) due to preformed thyroid hormone release from thyroid follicle destruction — not de novo synthesis. Because thyroid tissue is being destroyed rather than overstimulated, RAIU is low or suppressed (< 1–2% at 24 hours). Graves' disease (postpartum flare) is driven by stimulatory TSH-receptor antibodies (TRAb/TSHR-Ab) causing active hormone synthesis — RAIU is high (> 30–50%). TPO antibodies are positive in both but TSH-receptor stimulating antibodies (TRAb) are diagnostic of Graves'. RAIU is the key differentiating test.
Reference: Williams Obstetrics, 26th ed.
High-yield for: NEET PGINI-CETNExTFMGEUSMLEPLABMRCP
Written and medically reviewed by the StethoPrep medical team.